Lipocine Inc (LPCN)
$5.09
0.41 (8.76%)
LPCN Stock Quote Delayed 30 Minutes
6 Pharmaceutical Stocks to Buy Now
The grades of six pharmaceutical stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
27.06M
PE Ratio
-2.11
EPS
-2.41
Volume (Avg. Vol.)
19,793
Day's Range
$4.69 - $5.11
52-Week Range
$2.31 - $7.15
Dividend & Yield
N/A (N/A)
LPCN Stock Predictions, Articles, and Lipocine Inc News
3 Pharmaceutical Stocks to Sell Now
For the current week, the overall ratings of three pharmaceutical stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
5 Pharmaceutical Stocks to Sell Now
This week, the ratings of five pharmaceutical stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
3 Pharmaceutical Stocks to Sell Now
This week, the overall grades of three pharmaceutical stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
3 Pharmaceutical Stocks to Sell Now
The ratings of three pharmaceutical stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
5 Pharmaceutical Stocks to Sell Now
This week, the overall grades of five pharmaceutical stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
3 Pharmaceutical Stocks to Sell Now
This week, the ratings of three pharmaceutical stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
5 Stocks With Ugly Sales Growth — HTS MITT UEC LPCN MNKD
This week, these five stocks have the worst ratings in Sales Growth, one of the eight Fundamental Categories on Portfolio Grader.
5 Stocks With Crummy Sales Growth — HTS MITT UEC LPCN MNKD
This week, these five stocks have the worst ratings in Sales Growth, one of the eight Fundamental Categories on Portfolio Grader.
5 Stocks With Bad Sales Growth — HTS MITT UEC LPCN MNKD
This week, these five stocks have the worst ratings in Sales Growth, one of the eight Fundamental Categories on Portfolio Grader.
5 Stocks With Poor Sales Growth — HTS MITT UEC LPCN MNKD
This week, these five stocks have the worst ratings in Sales Growth, one of the eight Fundamental Categories on Portfolio Grader.
5 Stocks With Crummy Sales Growth — HTS MITT UEC LPCN MNKD
This week, these five stocks have the worst ratings in Sales Growth, one of the eight Fundamental Categories on Portfolio Grader.
5 Stocks With Ugly Sales Growth — HTS MITT UEC LPCN MNKD
This week, these five stocks have the worst ratings in Sales Growth, one of the eight Fundamental Categories on Portfolio Grader.
5 Stocks With Bad Sales Growth — HTS MITT LPCN MNKD UEC
This week, these five stocks have the worst ratings in Sales Growth, one of the eight Fundamental Categories on Portfolio Grader.
5 Stocks With Crummy Sales Growth — HTS MITT LPCN MNKD UEC
This week, these five stocks have the worst ratings in Sales Growth, one of the eight Fundamental Categories on Portfolio Grader.
5 Stocks With Bad Sales Growth — HTS MITT LPCN MNKD UEC
This week, these five stocks have the worst ratings in Sales Growth, one of the eight Fundamental Categories on Portfolio Grader.
5 Stocks With Awful Sales Growth — HTS MITT LPCN MNKD UEC
This week, these five stocks have the worst ratings in Sales Growth, one of the eight Fundamental Categories on Portfolio Grader.
5 Stocks With Bad Sales Growth — HTS MITT LPCN MNKD UEC
This week, these five stocks have the worst ratings in Sales Growth, one of the eight Fundamental Categories on Portfolio Grader.
